Medical ProductsCompany
Insulet M&A Summary
Insulet has acquired 2 companies, including 2 in the last 5 years. It has also divested 1 asset.
Insulet’s largest acquisition to date was in 2023, when it acquired Bigfoot Biomedical - Insulin Pump Patents for $25M. It’s largest disclosed sale occurred in 2016, when it sold Neighborhood Diabetes to Liberty Medical Holdings for $5M. Insulet has acquired in 1 US state. The Company’s most targeted sectors include information technology (50%) and medical products (50%).
Insulet Business Overview
Where is Insulet headquartered?
Insulet is headquartered in Acton, Massachusetts.
What is Insulet’s revenue?
Insulet disclosed revenue of 1,697M USD for 2023 and 1,305M USD for 2022.
How many employees does Insulet have?
Insulet has 3,000 employees.
What sector is Insulet in?
Insulet is a medical products company.
When was Insulet founded?
Insulet was founded in 2000.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity2
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 2
- M&A Advisors 2
Unlimited Searches
